Merck & Co. Inc. buy Barclays PLC
Start price
23.01.24
/
50%
€108.20
Target price
23.01.25
€124.16
Performance (%)
-14.23%
End price
24.01.25
€92.80
Summary
This prediction ended on 24.01.25 with a price of €92.80. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.23%. Barclays_PLC has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.89 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 0.963% | 0.963% | 20.321% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by Barclays_PLC for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Barclays PLC from $130.00 to $135.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.80
20.02.26
20.02.26
€119.08
20.02.27
20.02.27
0.96%
27.02.26
27.02.26
Stopped prediction by Barclays_PLC for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€98.90
07.10.24
07.10.24
€127.58
07.10.25
07.10.25
-23.46%
08.10.25
08.10.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€104.60
31.07.24
31.07.24
€131.14
31.07.25
31.07.25
-34.80%
01.08.25
01.08.25
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€116.60
02.02.24
02.02.24
€134.11
02.02.25
02.02.25
-18.18%
03.02.25
03.02.25